ELV

ELV

USD

Elevance Health Inc. Common Stock

$316.620+6.160 (1.984%)

Prix en Temps Réel

Healthcare
Healthcare Plans
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$310.460

Haut

$318.790

Bas

$310.000

Volume

0.89M

Fondamentaux de l'Entreprise

Capitalisation Boursière

70.4B

Industrie

Healthcare Plans

Pays

United States

Statistiques de Trading

Volume Moyen

1.99M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $273.71Actuel $316.620Haut $458.75

Actualités Connexes

Analyst Upgrades

Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400

Mizuho analyst Ann Hynes maintains Elevance Health with a Outperform and lowers the price target from $420 to $400.

Voir plus
Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400
Analyst Upgrades

JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394

JP Morgan analyst Lisa Gill maintains Elevance Health with a Overweight and raises the price target from $384 to $394.

Voir plus
JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394
Analyst Upgrades

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380

TD Cowen analyst Ryan Langston maintains Elevance Health with a Buy and raises the price target from $330 to $380.

Voir plus
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380
Analyst Upgrades

Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403

Wells Fargo analyst Stephen Baxter maintains Elevance Health with a Overweight and lowers the price target from $412 to $403.

Voir plus
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403
Reuters

Elevance beats profit estimates as health insurer keeps costs in check

Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check, sending its shares 3% higher in premarket trading.

Voir plus
Elevance beats profit estimates as health insurer keeps costs in check
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $359

Morgan Stanley analyst Erin Wright maintains Elevance Health with a Equal-Weight and raises the price target from $316 to $359.

Analyst Upgrades

Goldman Sachs Initiates Coverage On Elevance Health with Neutral Rating, Announces Price Target of $343

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health with a Neutral rating and announces Price Target of $343.

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.